Charge: 20272151 – Analyse-Datum: 12.10.2026 – Labor: Canalyse (unabhängiges Labor)

cannalin.
Cannabinoid Analysis
Batch 20272151

CBD Liposomal 4%

Independent laboratory analysis · analysis no. #302261

Tested forCannalinAnalysis no.#302261
Sample nameCBD Liposomal 4%Batch code20272151
Sample typeLiposomal CBDAnalysis date12-10-2026
LaboratoryCanalyseValid until11-10-2028

Cannabinoid composition

4,33 CBD 0,90 CBG 0,56 CBN 0,11 CBC 0,00 Δ9-THC 0,00 Δ8-THC 0,41 CBDV 0,00 THCV
CBD 4,33% CBG 0,90% CBN 0,56% CBC 0,11% CBDV 0,41% Other 93,69%

Results

CBD4,33 %Δ8-THC0,00 %
Δ9-THC0,00 %CBG0,90 %
CBN0,56 %CBC0,11 %
CBDV0,41 %THCV0,00 %
Total cannabinoids6,31 %
Original-Analysezertifikat (PDF) von Canalyse herunterladen